U.S. Psychedelic Mushroom Market Share To Reach Scalable Heights Of Growth

U.S. Psychedelic Mushroom Market Summary

The U.S. psychedelic mushroom market size was estimated at USD 2.25 billion in 2024 and is projected to grow at a CAGR of 11.5% from 2025 to 2030. The market is being shaped by a strong cultural and regulatory movement in favor of decriminalizing the use of psychedelic mushrooms as well as other naturally occurring entheogens. Several U.S. cities and states have already introduced policies to either decriminalize or legalize these substances. Such regulatory changes, combined with increasing public awareness and acceptance, have significantly boosted interest and consumer demand across therapeutic, recreational, and wellness applications.

Psychedelic mushrooms have demonstrated significant promise in addressing a range of mental health conditions, including depression, anxiety, post-traumatic stress disorder (PTSD), and addiction. Ongoing clinical research and clinical trials are further highlighting the therapeutic potential of psilocybin, the active compound found in psychedelic mushrooms. As scientific evidence grows and more healthcare professionals recognize the benefits, demand for these mushrooms in therapeutic contexts is expected to expand further, paving the way for increased adoption in mental health treatment frameworks.

Key Market Trends & Insights

• The Psilocybe segment accounted for a dominant revenue share of 90.0% in 2024. The high demand for psilocybe mushrooms is influenced by shifting public attitudes toward psychedelics, which are increasingly being perceived as viable wellness solutions rather than harmful drugs. In addition, the rapid expansion of research into their therapeutic potential and the broader trend toward natural and holistic health practices have accelerated acceptance, positioning Psilocybe as the leading category within the U.S. psychedelic mushroom market.
• The market for dried psychedelic mushrooms accounted for a revenue share of 56.7% in 2024. These products remain highly popular because they are considered natural and relatively safe for achieving altered states of consciousness. Moreover, growing consumer curiosity regarding psilocybin’s potential therapeutic applications is driving demand. The simplicity, accessibility, and cultural familiarity of dried mushrooms contribute to their wide use, both recreationally and in emerging wellness practices.
• The market for processed psychedelic mushrooms is projected to grow at a CAGR of 12.2% from 2025 to 2030. These include innovative product formats such as gummies, capsules, and infused edibles. Processed mushrooms are gaining traction as they are easier to consume, provide a more consistent psilocybin dosage, and offer convenience. Furthermore, the discreet nature of these products makes them particularly appealing to new users who may be hesitant to consume raw or dried mushrooms. This rising preference for standardized, user-friendly formats is expected to drive faster growth in this category compared to traditional forms.
• The recreational segment dominated the U.S. psychedelic mushroom industry and accounted for a revenue share of 28.3% in 2024. Recreational users are attracted to psychedelic mushrooms primarily for their ability to induce altered states of consciousness, euphoria, and enhanced creativity. Psilocybin, the key psychoactive compound, produces diverse effects on perception, mood, and cognition, making it popular among individuals seeking non-traditional wellness experiences. As societal attitudes continue to shift toward broader acceptance of psychedelics, recreational consumption is expected to remain an important contributor to the overall market.

Order a free sample PDF of the U.S. Psychedelic Mushroom Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 2.25 billion
• 2030 Projected Market Size: USD 4.32 billion
• CAGR (2025 - 2030): 11.5%

Key Companies & Market Share Insights

The U.S. psychedelic mushroom industry is expected to witness moderate competition among the companies owing to the presence of numerous players across the industry. Owing to changing consumer trends, numerous companies are expanding their product portfolio to gain a competitive edge in the market. Some of the key players include Shroomland, Galaxy Treats, Blissmushrooms, oneupmushroomsbar.com, Psychedelic Mushy, Psilocybin Lounge among others.

Manufacturers are increasingly engaged in R&D activities related to products that are used in the manufacturing of U.S. psychedelic mushrooms. They are also expanding their product portfolio to meet the growing demand for U.S. Psychedelic mushrooms from the application industry.

• In September 2023, Wiz Khalifa, a Grammy-winning rapper, launched a new brand called MISTERCAP'S, which is focused on promoting healthy living through culinary mushrooms, specifically non-psychedelic varieties. In partnership with Red Light Holland, which specializes in exotic mushrooms, MISTERCAP'S aims to educate consumers about the benefits of mushrooms while providing products such as at-home grow kits for Oyster, Shiitake, and Lion's Mane mushrooms.

Key Players

• Shroomland
• Galaxy Treats
• Blissmushrooms
• oneupmushroomsbar.com
• Psychedelic Mushy
• Psilocybin Lounge

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. psychedelic mushroom market is expanding rapidly, driven by regulatory reforms, growing research, and evolving consumer attitudes toward mental health and wellness. Psilocybe mushrooms dominate due to their strong therapeutic potential and cultural acceptance, while dried forms remain the most widely used. Processed products such as gummies and capsules are expected to gain momentum due to their convenience and standardization. The recreational segment contributes significantly to demand, while therapeutic adoption continues to rise with advancing clinical evidence. Overall, the market outlook is highly favorable, offering opportunities for innovation, investment, and broader mainstream integration in the coming years.